Cargando…

Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital

Introduction: Chronic liver disease (CLD) is a term used to describe a wide spectrum of disorders, including idiopathic, infectious, genetic, drug-induced, toxin-induced, and autoimmune disorders. The common consequence of chronic damage to the liver is cirrhosis. Cirrhotic patients are further clas...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauseef, Abubakar, Zafar, Maryam, Rashid, Behzad, Thirumalareddy, Joseph, Chalfant, Victor, Farooque, Umar, Mirza, Mohsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671171/
https://www.ncbi.nlm.nih.gov/pubmed/33214947
http://dx.doi.org/10.7759/cureus.11019
_version_ 1783610876678373376
author Tauseef, Abubakar
Zafar, Maryam
Rashid, Behzad
Thirumalareddy, Joseph
Chalfant, Victor
Farooque, Umar
Mirza, Mohsin
author_facet Tauseef, Abubakar
Zafar, Maryam
Rashid, Behzad
Thirumalareddy, Joseph
Chalfant, Victor
Farooque, Umar
Mirza, Mohsin
author_sort Tauseef, Abubakar
collection PubMed
description Introduction: Chronic liver disease (CLD) is a term used to describe a wide spectrum of disorders, including idiopathic, infectious, genetic, drug-induced, toxin-induced, and autoimmune disorders. The common consequence of chronic damage to the liver is cirrhosis. Cirrhotic patients are further classified by their severity based on the Child-Pugh scoring system. Currently, Child-Pugh scoring consists of ascites, hepatic encephalopathy (HE), prothrombin time, serum albumin level, and total bilirubin level. Lipid panel in CLD is a great marker in determining the severity of CLD. Method and methodology: It was a descriptive cross-sectional study conducted at a tertiary care hospital. A sample size of 122 was calculated by using a RaoSoft Digital Sample Size Calculator (RaoSoft, Inc., Seattle, WA) in which we used 5% as a margin of error, 95% as confidence interval (CI), 178 as population size, and response distribution as 50%. Non-complicated CLD patients having age in between 15 and 80 years with no cirrhotic complications including HE, spontaneous bacterial peritonitis, hepato-pumonary, or hepato-renal syndrome were included in our study; the rest of the CLD patients were excluded from our study. Results: The mean age of the study population was 47.09 ± 12.30 years with more than half of the patients lying among the age group 25-50 years. The study population included 76% of males (n=93) and 24% of females (n=29), with a mean age of females higher than the males. Diabetes mellitus (58.19%) was the most frequent comorbidity associated with CLD in subjects included in our study. Parameters of lipid panel were decreased exponentially as the severity of CLD increases from Child score A to C. Total cholesterol, low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), and triglyceride (TG) level decreased as the severity increases in our study. The mean model for end-stage liver disease (MELD) score increased as per hypothesized as the severity increases from Child score A to Child score C, respectively. Conclusion: Our study concluded that as the severity of CLD increases from Child class A to Child class C, the lipid panel profile decreases exponentially which proved the idea that had been hypothesized at the beginning of our study.
format Online
Article
Text
id pubmed-7671171
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-76711712020-11-18 Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital Tauseef, Abubakar Zafar, Maryam Rashid, Behzad Thirumalareddy, Joseph Chalfant, Victor Farooque, Umar Mirza, Mohsin Cureus Internal Medicine Introduction: Chronic liver disease (CLD) is a term used to describe a wide spectrum of disorders, including idiopathic, infectious, genetic, drug-induced, toxin-induced, and autoimmune disorders. The common consequence of chronic damage to the liver is cirrhosis. Cirrhotic patients are further classified by their severity based on the Child-Pugh scoring system. Currently, Child-Pugh scoring consists of ascites, hepatic encephalopathy (HE), prothrombin time, serum albumin level, and total bilirubin level. Lipid panel in CLD is a great marker in determining the severity of CLD. Method and methodology: It was a descriptive cross-sectional study conducted at a tertiary care hospital. A sample size of 122 was calculated by using a RaoSoft Digital Sample Size Calculator (RaoSoft, Inc., Seattle, WA) in which we used 5% as a margin of error, 95% as confidence interval (CI), 178 as population size, and response distribution as 50%. Non-complicated CLD patients having age in between 15 and 80 years with no cirrhotic complications including HE, spontaneous bacterial peritonitis, hepato-pumonary, or hepato-renal syndrome were included in our study; the rest of the CLD patients were excluded from our study. Results: The mean age of the study population was 47.09 ± 12.30 years with more than half of the patients lying among the age group 25-50 years. The study population included 76% of males (n=93) and 24% of females (n=29), with a mean age of females higher than the males. Diabetes mellitus (58.19%) was the most frequent comorbidity associated with CLD in subjects included in our study. Parameters of lipid panel were decreased exponentially as the severity of CLD increases from Child score A to C. Total cholesterol, low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), and triglyceride (TG) level decreased as the severity increases in our study. The mean model for end-stage liver disease (MELD) score increased as per hypothesized as the severity increases from Child score A to Child score C, respectively. Conclusion: Our study concluded that as the severity of CLD increases from Child class A to Child class C, the lipid panel profile decreases exponentially which proved the idea that had been hypothesized at the beginning of our study. Cureus 2020-10-18 /pmc/articles/PMC7671171/ /pubmed/33214947 http://dx.doi.org/10.7759/cureus.11019 Text en Copyright © 2020, Tauseef et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Tauseef, Abubakar
Zafar, Maryam
Rashid, Behzad
Thirumalareddy, Joseph
Chalfant, Victor
Farooque, Umar
Mirza, Mohsin
Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital
title Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital
title_full Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital
title_fullStr Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital
title_full_unstemmed Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital
title_short Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital
title_sort correlation of fasting lipid profile in patients with chronic liver disease: a descriptive cross-sectional study in tertiary care hospital
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671171/
https://www.ncbi.nlm.nih.gov/pubmed/33214947
http://dx.doi.org/10.7759/cureus.11019
work_keys_str_mv AT tauseefabubakar correlationoffastinglipidprofileinpatientswithchronicliverdiseaseadescriptivecrosssectionalstudyintertiarycarehospital
AT zafarmaryam correlationoffastinglipidprofileinpatientswithchronicliverdiseaseadescriptivecrosssectionalstudyintertiarycarehospital
AT rashidbehzad correlationoffastinglipidprofileinpatientswithchronicliverdiseaseadescriptivecrosssectionalstudyintertiarycarehospital
AT thirumalareddyjoseph correlationoffastinglipidprofileinpatientswithchronicliverdiseaseadescriptivecrosssectionalstudyintertiarycarehospital
AT chalfantvictor correlationoffastinglipidprofileinpatientswithchronicliverdiseaseadescriptivecrosssectionalstudyintertiarycarehospital
AT farooqueumar correlationoffastinglipidprofileinpatientswithchronicliverdiseaseadescriptivecrosssectionalstudyintertiarycarehospital
AT mirzamohsin correlationoffastinglipidprofileinpatientswithchronicliverdiseaseadescriptivecrosssectionalstudyintertiarycarehospital